Table 4.
Viral findings related to infantile wheezing | P | |||
---|---|---|---|---|
Rhinovirus only (n = 19) n (%) | Other/No virus (n = 60) n (%) | |||
Decreased lung function † | ||||
Anti‐inflammatory therapy ‡ | No | 1 (5) | 8 (13) | 0.294 |
Yes | 4 (21) | 5 (8) | ||
Normal lung function § | ||||
Anti‐inflammatory therapy ‡ | No | 5 (26) | 36 (60) | 0.008 |
Yes | 9 (47) | 11 (18) | ||
Fall in FEV1≥12% after exercise | ||||
Anti‐inflammatory therapy ‡ | No | 1 (5) | 5 (8) | 0.027 |
Yes | 4 (21) | 0 (0) | ||
Fall in FEV1 <12% after exercise | ||||
Anti‐inflammatory therapy ‡ | No | 5 (26) | 39 (65) | 0.014 |
Yes | 9 (47) | 16 (27) |
†FEV1 <80% or FEV1/FVC <88% or FEF50% <62% of the predicted value; ‡ongoing inhaled steroid or cromone therapy; §FEV1≥80% and FEV1/FVC ≥88% and FEF50%≥62% of the predicted value.
FEV1, forced expiratory flow in 1 s.